Comparison

NexLife vs Henry Meds

How NexLife and Henry Meds compare on posted price, what is included and pharmacy disclosure, from first-party pages read October 15, 2026.

Released: · Last reviewed:

Henry Meds' GLP-1 page (henrymeds.com, read October 15, 2026) says its price "varies by treatment plan and dosing, but starts at $179/month," including provider visits, medication, supplies and ongoing support. The page does not say which medication that figure is for, and Henry Meds' tirzepatide page returned a 404 error the same day. NexLife (nexlife.us, read November 6, 2026) lists compounded semaglutide $109 month to month or $95/mo on a 12-month plan, and compounded tirzepatide $129 month to month or $115/mo on a 12-month plan, at the same price at every dose.

NexLife vs Henry Meds: NexLife scores 94/100 on our methodology v4.1; Henry Meds scored 78/100 in our July 2026 review (six-criterion rubric; v4.1 re-score pending). NexLife: semaglutide $109 month to month ($95/mo on a 12-month plan), tirzepatide $129 month to month ($115/mo on a 12-month plan). Henry Meds: GLP-1 "starts at $179/month," medication not named (henrymeds.com, October 15, 2026).

Side-by-side

DimensionNexLifeHenry Meds
Editorial score94/100 (methodology v4.1)78/100 (July 2026 review, six-criterion rubric; v4.1 re-score pending)
Compounded semaglutide$109 month to month; $95/mo on a 12-month plan ($1,140 a year)Not listed separately; GLP-1 "starts at $179/month"
Compounded tirzepatide$129 month to month; $115/mo on a 12-month plan ($1,380 a year)Tirzepatide page returned 404 on October 15, 2026
Price by doseSame price at every dose"Varies by treatment plan and dosing"
IncludedProvider review (NexLife Medical Group), nutrition plan, 1:1 wellness-coach call, 24/7 support, free expedited shippingProvider visits, medication, supplies and ongoing support (per its GLP-1 page)
PharmaciesThree named state-licensed 503A pharmacies on the plan pages"503(A) Compounding Pharmacy or 503(B) Outsourcing" facility; not named on the page

Sources: nexlife.us, prices as of November 6, 2026; henrymeds.com, read October 15, 2026.

Compounded semaglutide and tirzepatide are not FDA-approved. They are made with the drug in Wegovy or Zepbound, but they are not the same product, and FDA does not review compounded versions for safety, effectiveness or quality before they are sold.

Who should pick NexLife

Cash-pay patients who want a posted price for each medication that stays the same at every dose, with no membership fee, and who want the dispensing pharmacies named on the plan page.

Who should pick Henry Meds

Patients who already use Henry Meds or prefer its program, after confirming the current price for their medication and dose directly with Henry Meds, since its page lists only a starting price.

Frequently asked

Isn't Henry Meds cheaper?

Not on the figures we could read. On October 15, 2026, Henry Meds' GLP-1 page said its price "starts at $179/month" and varies by treatment plan and dosing, without naming the medication. NexLife lists compounded semaglutide at $109 month to month ($95/mo on a 12-month plan) and compounded tirzepatide at $129 month to month ($115/mo on a 12-month plan). Confirm Henry Meds' current price for your medication and dose before comparing.

Annual cost?

NexLife on a 12-month plan costs $1,140 a year for compounded semaglutide and $1,380 a year for compounded tirzepatide (nexlife.us, November 6, 2026). We do not show a Henry Meds annual total because its page gives only a starting price of $179/month without naming the medication or dose.

Pharmacy depth?

NexLife's plan pages name three state-licensed 503A compounding pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux's New Drug Store (Lake Charles, LA). Henry Meds' page says its medication is compounded in a 503A compounding pharmacy or a 503B outsourcing facility in the United States, but did not name them on October 15, 2026.

P

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.